APA (7th ed.) Citation

Chu, C., Schönbrunn, A., Fischer, D., Liu, Y., Hocher, J., Weinerth, J., . . . Hocher, B. (2023). Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients. Frontiers in immunology, 14, . https://doi.org/10.3389/fimmu.2023.1187880

Chicago Style (17th ed.) Citation

Chu, Chang, et al. "Immune Response of Heterologous Versus Homologous Prime-boost Regimens with Adenoviral Vectored and MRNA COVID-19 Vaccines in Immunocompromised Patients." Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1187880.

MLA (9th ed.) Citation

Chu, Chang, et al. "Immune Response of Heterologous Versus Homologous Prime-boost Regimens with Adenoviral Vectored and MRNA COVID-19 Vaccines in Immunocompromised Patients." Frontiers in Immunology, vol. 14, 2023, https://doi.org/10.3389/fimmu.2023.1187880.